HB 5494 Rhode Island House · 2021 Regular Session

AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- DRUG COST TRANSPARENCY (Provides drug cost transparency by requiring reports be submitted by drug manufacturers, pharmacy benefit managers and health benefit plan insurers to the director of the department of business regulation regarding drug prices and increases the prices.)

Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2021
Committee Review
Floor Vote
Governor
Introduced Feb 11, 2021 Last action Mar 8, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
1
Committee
1
Mar 8, 2021
Legislature · Passed
03/08/2021 Committee recommended measure be held for further study
legislature
Feb 11, 2021
Introduced
02/11/2021 Introduced, referred to House Health & Human Services
lower
8 primary · 0 co-sponsors

Sponsors